Fluoxetine in Early Poststroke Depression

Completed

Phase N/A Results

Summary of Purpose

To study the efficacy and tolerance of fluoxetine (FLX) in the treatment of early poststroke depression (PSD).

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 14 August 2001.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Sponsors

  • Lilly France Laboratory

Trial Design

Multi-center, randomized, double-blind, placebo-controlled trial of 31 patients.

Contacts

  • Laurent Wiart, MD, Tour de Gassies, Neurorehabilitation Unit, 33520 Bruges, France.

    Wiartl@aol.com